[HTML][HTML] SARS-CoV-2 S and N protein peptides drive invasion abilities of colon cancer cells through TGF-β1 regulation

WM Ciszewski, LA Wozniak, K Sobierajska - Biochimica et Biophysica Acta …, 2023 - Elsevier
The COVID-19 pandemic led to the delay of colorectal cancer (CRC) diagnosis, which
causes CRC to be treated at more advanced, often metastatic stages. Unfortunately, there is …

[HTML][HTML] COVID-19 patients' sera induce epithelial mesenchymal transition in cancer cells

Y Saygideger, A Sezan, A Candevir, BS Demir… - Cancer Treatment and …, 2021 - Elsevier
Abstract Covid-19 Pneumonia of SARS-CoV-2 pandemic infection, persists to have high
disease burden especially in cancer patients. Increased inflammation and thromboembolic …

[HTML][HTML] SARS-CoV-2 M protein facilitates malignant transformation of breast cancer cells

HNT Nguyen, M Kawahara, CK Vuong… - Frontiers in …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) has spread faster due to the emergence of SARS-
CoV2 variants, which carry an increased risk of infecting patients with comorbidities, such as …

[HTML][HTML] Possibility of SARS-CoV-2 Infection in the Metastatic Microenvironment of Cancer

T Hayashi, K Sano, I Konishi - Current Issues in Molecular Biology, 2022 - mdpi.com
According to a report from the World Health Organization (WHO), the mortality and disease
severity induced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …

[HTML][HTML] Deciphering the relationship between SARS-CoV-2 and cancer

M Costanzo, MAR De Giglio, GN Roviello - International Journal of …, 2023 - mdpi.com
Some viruses are known to be associated with the onset of specific cancers. These
microorganisms, oncogenic viruses or oncoviruses, can convert normal cells into cancer …

[HTML][HTML] Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?

S Sinha, CN Kundu - Medical Oncology, 2021 - Springer
The COVID-19 pandemic has engulfed the entire world and has claimed more than 3 million
lives worldwide. This viral disease is caused by severe acute respiratory syndrome …

SARS-CoV-2 M-protein promotes malignancy of breast cancer cells and alters interaction in breast tumor microenvironment

THN Nguyen, M Usuda, S Park, CK Vuong… - European Journal of …, 2024 - ejcancer.com
Background: The spread of the COVID-19 pandemic significantly influences cancer patients,
not only in terms of cancer care but also cancer progression after SARS-CoV-2 viral …

[HTML][HTML] Cancer progression in COVID-19: integrating the roles of renin angiotensin aldosterone system, angiopoietin-2, heat shock protein-27 and epithelial …

A Saha, P Anirvan - Ecancermedicalscience, 2020 - ncbi.nlm.nih.gov
The ongoing coronavirus disease 2019 (COVID-19) pandemic has affected millions
worldwide and has been found to cause severe disease in patients with underlying …

[HTML][HTML] The effect of COVID-19 derived cytokine storm on cancer cells progression: double-edged sword

M Heydarian, M Mohammadtaghizadeh… - Molecular Biology …, 2022 - Springer
Objective Severe acute respiratory syndrome coronavirus 2 (SARS-COV2) was first detected
in Wuhan, China in December, 2019. The emerging virus causes a respiratory illness, that …

[HTML][HTML] Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail

YJ Lai, CH Chao, CC Liao, TA Lee, JM Hsu… - American journal of …, 2021 - ncbi.nlm.nih.gov
The engagement of human angiotensin-converting enzyme 2 (hACE2) and SARS-CoV-2
spike protein facilitate virus spread. Thus far, ACE2 and TMPRSS2 expression is correlated …